TickerKhojComparison · NSE · data 2026-11-02
Biofil Chemicals & Pharmaceuticals Ltd. vs Lasa Supergenerics Ltd.
In plain words
Size: Biofil Chemicals & Pharmaceuticals Ltd. is about 1.9 times the market value of Lasa Supergenerics Ltd..
Return on equity: Biofil Chemicals & Pharmaceuticals Ltd. 13.8% vs Lasa Supergenerics Ltd. -51.1%.
Debt to equity: Lasa Supergenerics Ltd. 0.2 vs Biofil Chemicals & Pharmaceuticals Ltd. 0.14.
Differences in the numbers, not a recommendation of either stock.
Side by side
| BIOFILCHEM | LASA | |
|---|---|---|
| Price | ₹29.05 | ₹4.44 |
| Market cap | ₹47 cr | ₹25 cr |
| P/E | 97.7 | — |
| P/B | — | — |
| ROE | 13.8% | -51.1% |
| ROCE | 1.8% | -27.0% |
| Debt / equity | 0.14 | 0.2 |
| Operating margin | 1.5% | -224.5% |
| Dividend yield | 0.00% | 0.00% |
| Sales growth, 3 years (yearly) | -1.9% | -42.1% |
| Profit growth, 3 years (yearly) | 70.7% | — |
| 1-year return | -24.7% | -61.3% |
| Revenue, last 12 months | ₹34 cr | ₹6 cr |
| Net profit, last 12 months | ₹0 cr | ₹-17 cr |
| Latest quarter | Jun 2026 | Jun 2026 |
| Quarter net profit | ₹0 cr | ₹-4 cr |
| Quarter profit vs a year earlier | -95.4% | — |
| Promoter holding | 46.79% | 53.65% |
| Health check | Weak (2.7/10) | Weak (0/10) |
Common questions
Which earns a higher return on equity?
Biofil Chemicals & Pharmaceuticals Ltd. (13.8% against -51.1%).
Which carries more debt?
Lasa Supergenerics Ltd. has the higher debt-to-equity ratio (0.2 against 0.14).